| 17 Jan 2024 | 08:15:00 | Cancellation of listing and admission to trading |
| 17 Jan 2024 | 08:00:00 | Cancellation - Dechra Pharmaceuticals Plc |
| 17 Jan 2024 | 07:30:00 | Holding(s) in Company |
| 16 Jan 2024 | 16:54:02 | Holding(s) in Company |
| 16 Jan 2024 | 15:29:00 | Form 8.3 - Dechra Pharmaceuticals plc |
| 1 Nov 2023 | Dechra Pharmaceuticals PLC - 2023 Annual Report | |
| 30 Oct 2023 | Dechra Pharmaceuticals PLC - 2023 Annual Report | |
| 20 Sep 2022 | Dechra - 2022 Annual Financial Report |
Dechra is a worldwide company that specializes in producing and selling top-quality veterinary pharmaceuticals and related products. Our focus is on creating products that are specifically designed for veterinarians, and we are dedicated to developing, manufacturing, marketing, and selling these products to veterinary professionals around the globe.
| 17 Jan 2024 | 08:15:00 | Cancellation of listing and admission to trading |
| 17 Jan 2024 | 08:00:00 | Cancellation - Dechra Pharmaceuticals Plc |
| 17 Jan 2024 | 07:30:00 | Holding(s) in Company |
| 16 Jan 2024 | 16:54:02 | Holding(s) in Company |
| 16 Jan 2024 | 15:29:00 | Form 8.3 - Dechra Pharmaceuticals plc |
| 1 Nov 2023 | Dechra Pharmaceuticals PLC - 2023 Annual Report | |
| 30 Oct 2023 | Dechra Pharmaceuticals PLC - 2023 Annual Report | |
| 20 Sep 2022 | Dechra - 2022 Annual Financial Report |
Dechra is a worldwide company that specializes in producing and selling top-quality veterinary pharmaceuticals and related products. Our focus is on creating products that are specifically designed for veterinarians, and we are dedicated to developing, manufacturing, marketing, and selling these products to veterinary professionals around the globe.
